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Background: Thermobifida fusca is a cellulolytic bacterium with potential to be used as a platform organism for
sustainable industrial production of biofuels, pharmaceutical ingredients and other bioprocesses due to its
capability of potential to convert plant biomass to value-added chemicals. To best develop T. fusca as a bioprocess
organism, it is important to understand its native cellular processes. In the current study, we characterize the
metabolic network of T. fusca through reconstruction of a genome-scale metabolic model and proteomics data.
The overall goal of this study was to use multiple metabolic models generated by different methods and comparison
to experimental data to gain a high-confidence understanding of the T. fusca metabolic network.
Results: We report the generation of three versions of a metabolic model of Thermobifida fusca sp. XY developed
using three different approaches (automated, semi-automated, and proteomics-derived). The model closest to in vivo
growth was the proteomics-derived model that consists of 975 reactions involving 1382 metabolites and account for
316 EC numbers (296 genes). The model was optimized for biomass production with the optimal flux of 0.48 doublings
per hour when grown on cellobiose with a substrate uptake rate of 0.25 mmole/h. In vivo activity of the DXP pathway
for terpenoid biosynthesis was also confirmed using real-time PCR.
Conclusions: iTfu296 provides a platform to understand and explore the metabolic capabilities of the actinomycete T. fusca
for the potential use in bioprocess industries for the production of biofuel and pharmaceutical ingredients. By comparing
different model reconstruction methods, the use of high-throughput proteomics data as a starting point proved to be the
most accurate to in vivo growth.
Keyword: Metabolic Modeling, Flux Balance Analysis, Constraint Based Modeling, Actinomycete, Thermobifida fusca,
Proteomics Profiling, Terpenoids Biosynthesis Pathway, DXP Pathway, Mevalonate Pathway, BiofuelBackground
With ongoing research in genomics, metagenomics, and
bioprospecting, the breadth of novel and interesting bio-
chemistry continues to grow. One of the current chal-
lenges associated with the large amount of data and
resources available is to conduct detailed analyses to cur-
ate information to translate raw data into knowledge that
provides functional insight. One computational method
that facilitates metabolic analysis and dovetails well with
genomic and biochemical information is genome-scale* Correspondence: ssfong@vcu.edu
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have benefits of being easily scalable and providing gene-
protein-reaction level specificity, there are a number of
limitations. One of the most fundamental problems re-
volves around the fact that metabolic networks are under-
determined and thus, there exist alternative flux states with
different pathway usage that produce indistinguishable
cellular phenotypes. This is an underlying problem
with constraint-based models that impacts multiple
facets of these models including the initial reconstruc-
tion (association of specific reactions with annotatedtd. This is an Open Access article distributed under the terms of the Creative
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alternate optimal solutions). In this study, we consider the
metabolically under-characterized actinobacterium, Ther-
mobifida fusca, and utilize three different methods to gain
a better understanding of its metabolic network and iden-
tify preferred methodologies for network characterization.
Thermobifida fusca
Within the actinomycetes, Thermobifida fusca (aerobic,
thermophilic, gram-positive) is known for its high
temperature and pH stability as well as highly expressed
cellulolytic system. The cellulolytic system is comprised of
three endocellulases (Cel9B, Cel6A and Cel5A), two exo-
cellulases (Cel6B and Cel48A) and a processive cellulase
(Cel9A) [1]. Numerous studies in the past have reported
on various facets of the ability of T. fusca to degrade ligno-
cellulosic biomass. Due to the high efficiency with which
T. fusca can process lignocellulosic materials, efforts have
been made to clone several individual cellulase genes into
Streptomyces lividians, Streptomyces albus, Bacillus
subtilis [2] and Escherichia coli [3,4]. The cloned en-
zymes were isolated in good concentrations but failed
to show similar level of cellulolytic activity as is found
in T. fusca. This may be due to the complexity of cellu-
lose degradation systems that are not defined by a few
genes but is an intertwined network of various enzymes
[1,5]. Hence, it is suggested that the best way to fully
utilize the cellulolytic capabilities of T. fusca may be to de-
velop T. fusca rather than trying to move its cellulases into
other systems by heterologous expression.Figure 1 The prospective use of cellulolytic microbes such as T. fusca m
bioprocess there by reducing the need of pretreatment of plant bioma
denotes the cellulolytic capabilities of microbes such as T. fusca and Bacteria-Actinomycetes have historically been involved in the bio-
logical production of a variety of antifungals, antibiotics,
and chemotherapeutics. Some of these compounds include
siderophores [6], polyketides [7,8] and terpenes [9,10].
As a cellulolytic actinomycete, T. fusca may present an
interesting opportunity for consolidated bioprocessing -
CBP (Figure 1) of raw lignocellulosic material to value-
added biobased products.
The ability to produce chemicals of industrial import-
ance using inexpensive lignocellulosic biomass has been
a recent focus for microbial systems. For T. fusca, the se-
quencing of its genome by Department of Energy (DOE)
in 2005 sets up a milestone towards understanding this
industrially applicable microbe [11]. Besides proving an
excellent host microbe for biofuel production [12], it
also showed success towards utilization of untreated
(without any preprocessing) lignocellulosic material. This
is a promising development toward making use of the cel-
lulolytic capabilities of this microbe to reduce the complex
multi-step bioprocess to a CBP [13].
Different approaches have been taken in the past in try-
ing to develop a consolidated bioprocess. One approach is
to utilize the cellulolytic capabilities to well-established
model organisms, such as E. coli and S. cerevisiae [1]. This
approach seeks to allow for direct use of lignocellulosic
biomass as a starting point, but leverages the knowledge
and tools available for well-characterized organisms.
The alternative approach is to characterize and develop
poorly-characterized cellulolytic organisms. Thus, high
levels of cellulose processivity can be achieved, but theay help in reducing the multiple steps towards the fermentation
ss to feed into an industrial process as a source of carbon. Bacteria-X
Y denotes the fermentations potentials of industrial microbes
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cient level that metabolism can be designed and altered in
a directed fashion.
In studying T. fusca, we believe that it can be devel-
oped into a facile cellulolytic system for consolidated
bioprocessing. In 2011, Deng and Fong established a
genetic modification protocol for genetic engineering of
T. fusca and demonstrated this system through the pro-
duction and optimization of propanol [12]. The initial
developments in the characterization of T. fusca are
listed in Table 1. Following along the same lines, we
continue to further understand the other capabilities of
robust cellulolytic system of actinomycete for use in
manufacturing industries. Thus, our group aims to present
a systems level understanding of metabolic network of
T. fusca.
Metabolic models
With the availability of genomic sequences, it has become
possible to use genome annotation and biochemical infor-
mation to reconstruct cellular metabolic networks [14].
These models can be used for simulating the living state of
bacteria, if operated under the defined constraints and
boundary conditions. There are various algorithms such as
FBA - flux balance analysis [15,16], MOMA - minimization
of metabolic adjustments [17], ROOM - regulatory on-off
minimization [18] and MCA - metabolic control analysis
that are currently used for the purpose of running compu-
tational simulations of these models [19]. In the current
study, we used FBA, which is based on linear program-
ming, to simulate and optimize T. fusca model developed
in this study for biomass production (growth).
T. fusca model and FBA
Whole genome sequence and annotation of T. fusca [11]
was used to build a genome-scale metabolic reconstruc-
tion to understand the underlying metabolic pathways and
network in T. fusca [11,12,20]. The reaction database used
for drafting the model includes but is not limited to





2004-2006 Plant biomass degradation study and analysis of
enzymatic system
2007 Sequence Annotation
2010 First Genetic Modification
2011 Producing biofuel from untreated biomass[24], UniProt [25] and MBRole [26]. Information from
disparate databases were tabulated to form an in-house
reaction database as illustrated in Figure 2.
The process of compiling biochemical reactions leads
to the formulation of a draft model of T. fusca, however,
at this stage the represented metabolic network inevit-
ably is incomplete and has numerous metabolic gaps.
Thus, any initial model that is generated undergoes a
gap-filling step. For our models, gap-filling was initially
performed using a computational gap-filling algorithm
[27-30]. After gap-filling, simulations can be run by spe-
cifying input constraints such as substrate uptake rate
or oxygen uptake rate. Once the model provides a
framework to understand the cellular process, it can be
used to find target for focused metabolic engineering
to yield products of biotechnological value [31]. The
most widely-used algorithms for design and simulation
of genome-scale constraint-based metabolic models
such as OptKnock [32], OptForce [33], EMiLio [34]
are based on flux distribution and flow through chem-
ically balanced reactions (FBA). Flux balance analysis
(FBA) uses linear programming to optimize the object-
ive function as follows:
Maximize : Z
Subject to : Sv ¼ 0;
ai≤vi≤ bi for all reactions i;
where, Z is the flux through objective function (bio-
mass production and product optimization), S: stoichi-
ometry of the reactions represented as matrix, v is
reaction flux vector, ai and bi are the constraints placed
on the flux vi of the reaction i [35].
Even after compiling biochemical information and
gap-filling a model, there often are discrepancies be-
tween the computational model results and in vivo states
that are difficult to identify using only computational ap-
proaches. An additional level of model curation can be
achieved by integrating high-throughput experimental
data with the framework of a computational model to put
“content in context” [35]. This data integration can becterization
Group Citation
Zhang et al. Int. J Syst Bact. 1998 Apr
Kukolya et al. Int. J Sys Evol Micr, 2002 Jul
DOE JGI Finished Genome, 2005
Wilson et al. Chem Rec. 2004
Biochem. 2006 Nov
Lykidis et al. J. Bacteriol. 2007 Mar
Deng & Fong Appl. Environ. Microbiol 2010 Apr
Deng & Fong Metab Eng. 2011 Sept
Figure 2 Illustration of available database used for compiling the MetModel reaction database.
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such as transcriptomics, proteomics and metabolomics.
This step reconciles in silico predictions with experimental
results and thereby helps enhance the characterization of
the cellular activity.
Genome-scale metabolic models have been created
for many prokaryotic microbes and a variety of appli-
cations [23]. Several of these models have been able to
incorporate experimental data to more closely match
cellular processes. Once the model closely resembles a
biological system, it can be optimized for defined ob-
jective function. This objective function may range
from production of biomass to production of a chem-
ical target. Following the in silico optimization of yields
the computational design may eventually be replicated for
applications in industry, therapeutics or health-related
predictions.
In this study, three different approaches for generating
constraint-based models were used and analyzed for
their ability to accurately predict cellular growth when
given an input substrate uptake rate. The three model
versions were 1) designed using Model SEED [36], 2) an
in-house semi-automated reconstruction based on or-
ganism specific annotation and reaction information
from KEGG [21,22], and 3) a proteomics-based model
from 2D proteomic experiment of T. fusca grown on cel-
lobiose media. A comparative analysis between the different
models was conducted to develop the most experimentally
accurate model of T. fusca and to provide comparison of dif-
ferent model generation methods. Detailed analysis of
metabolic function of T. fusca is also included to pro-
vide perspective on potential industrial applications
(eg: in biofuel and natural product) for development of
consolidated bioprocesses using T. fusca. Here we will
be discussing the mevalonate and non-mevalonate pathways
for terpenoid biosynthesis. These pathways are utilized for
the production of isoprenoid precursor (isopentenyl pyro-
phosphate and dimethylalyl pyrophosphate) compounds
that have applications in pharmaceutical, nutraceutical
and perfume industries.Results and discussion
T. fusca is known to directly use lignocellulosic biomass
as a carbon substrate due to its well-studied cellulolytic
system [1,37]. In laboratory conditions, T. fusca can
grow on a variety of substrates including glucose, cello-
biose, and microcrystalline cellulose. To match experi-
mental work conducted as part of this study on cellobiose,
it was necessary to add cellobiose degradation reactions to
the draft model based upon the annotation and experi-
mental evidence (EC 3.2.1.21, Tfu_0937). Three versions
of a T. fusca model were created, as shown in Figure 3,
using three different approaches to compare model-
building approaches and models were tested against ex-
perimental growth on cellobiose. In the process of model
reconstruction, activity of terpenoid pathways was uncer-
tain, but was experimentally verified using real-time PCR.
Metabolic reconstruction: summary and model statistics
Three different draft metabolic models were constructed
for Thermobifida fusca. The three models varied based
upon what was used as the starting point for generating
the initial reaction list for the model (Model SEED,
KEGG, proteomics data). In all cases, after initial gener-
ation of a reaction list, all reactions were associated with
KEGG IDs to standardize comparisons between models.
Tfu_v1: The taxonomy number of T. fusca was used
to generate a draft model from Model SEED (Tfu_v1)
[36,38]. The Model SEED output was then converted to
KEGG compound identifiers before running gap analysis
and FBA. The Model SEED-derived Tfu_v1 model con-
tained 1302 reactions, 1213 metabolites, and 618 EC
numbers. Gap analysis added 146 reactions that primar-
ily include a variety of exchange reactions (reactions that
denote the direct uptake/secretion of the respective me-
tabolite from or to the extra cellular media). When used
with unconstrained carbon input flux (cellobiose uptake
of 1000 mmoles/gDW/h) the Tfu_v1 model calculated a
growth rate of 24.25 doublings/h. However, when the ex-
perimentally determined substrate uptake rate of cellobi-
ose (0.25 mmoles/gDW/h) was applied to this model it
Figure 3 Flowchart of the model building step and data incorporation for all the three version of the model. Genomics and Proteomics
are the high throughput datasets used for building the models. SUR – Substrate uptake rate for cellobiose as calculated experimentally was
applied as a constraint. Red indicated no solution was obtained when running simulation of SEED model under experimental constraints. Values
in the green boxes indicate the growth rates for Tvu_v2 and Tfu_v3.
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solution). This infeasibility was crosschecked and veri-
fied by using the Model SEED FBA runs. The model
failed to perform under any media formulations (glucose
and cellobiose) attempted using the Model SEED simu-
lation platform.
Tfu_v2: The second version of a T. fusca model
(Tfu_v2) was created using an in-house semi-automated
reconstruction method as defined in our past publica-
tions [27,28]. This model consists of 1002 reactions involv-
ing 584 EC numbers and accounting for 1105 metabolites.
Eight out of 48 reactions added in the gap analysis were
non-exchange reactions. Applying the experimentally deter-
mined constraint of substrate uptake rate for cellobiose as
0.25 mmoles/gDW/h, the optimal biomass growth was
72.84 doublings/h. This growth rate was compared to ex-
perimental growth rate of 0.43 doublings/h.
Tfu_v3: The third version of the model generated in this
study (Tfu_v3) is based on proteomic experimental data
generated by our group in collaboration with the Manitoba
Centre for Proteomics & Systems Biology, the University
of Manitoba. The detailed protein characterization of
T. fusca based on this data is beyond the scope of this
paper and will be explained in future publications along
with the other experimental data. This method of generat-
ing a model varied from Tfu_v1 and Tfu_v2 as the initial
reaction list was populated from reactions associated with
experimentally detected proteins, not informatics-based
annotation. The Tfu_v3 model contains 975 reactions,
1382 metabolites, and 316 EC numbers (296 unique genes
annotated in T. fusca). FBA simulations with an inputconstraint of a cellobiose uptake rate of 0.25 mmoles/
gDW/h gave a predicted growth rate of 0.49 doublings/h
(for reference experimentally determined growth rate is
0.43 doublings/h). A comparison of the model contents
(by reaction) is summarized in Figure 4 and the detailed
model in all three versions is attached as Additional file 1
(Model.xls).
Due to the critical role of central metabolism to het-
erotrophic organisms, an analysis was conducted using
all three model versions to study central metabolism. To
study the individual pathways in carbohydrate metabol-
ism and amino acid metabolism, each metabolic pathway
was annotated using EC numbers recorded in KEGG.
The summary table is shown in Table 2. Genes within
a pathway were tabulated to evaluate the completeness
of given pathway. At the first glance, all the pathways
with a gene presence of 20% or above were counted as
present/active.
Tfu_v3: proteomics model reaction distribution
Based upon the initial model contents and growth rate
simulation results, the the Tfu_v3 appears to most
closely predict experimental results. Thus, further de-
tailed computational analyses of T. fusca are based on
the Tfu_v3 model. The Tfu_v3 model is designated as
iTfu296 (represents 296 annotated genes).
The proteomics-based model of T. fusca accounts for
216 amino acid reactions and 182 carbohydrate-related
reactions as illustrated in Figure 5. When running an
FBA simulation to maximize growth with an input cello-
biose uptake of 0.25 mmoles/gDW/h, 110 reactions were
Figure 4 Summary of three versions of models created in this
study: Reaction distribution across the 3 versions is
represented in the figure. All three versions had 170 reactions in
common. Following was the common reaction across each
compared pair of model versions: Tfu_v1: SEED AND Tfu_v2:yaml:
195, Tfu_v2:yaml AND Tfu_v3: Proteomics: 417, Tfu_v1: SEED AND
Tfu_v3: Proteomics: 185.
Table 2 Summary of individual pathway contrasts between










Glycolysis/Gluconeogenesis 45 28 62% 22 49% 15 33%
Citrate Cycle (TCA Cycle) 22 15 68% 15 68% 13 59%
Pentose Phosphate Pathway 40 20 50% 15 38% 13 33%
Pentose and Glucuronate
Intrconv.
61 10 16% 8 13% 6 10%
Fructose and Mannose
Metabolism
65 14 22% 14 22% 5 8%
Galactose Metabolism 38 12 32% 13 34% 8 21%
Starch and Sucrose
Metabolism
74 14 19% 14 19% 12 16%
Amino Sugar and Nucleotide
Metabolism
108 25 23% 21 19% 15 14%
Pyruvate Metabolism 64 26 41% 17 27% 15 23%
Glyoxylate and Dicarboxylate
Metabolism
66 12 18% 11 17% 7 11%
Propanoate Metabolism 47 17 36% 14 30% 12 26%
Butanoate Metabolism 50 17 34% 12 24% 7 14%
C- 5 Branched Diabasic Acid
Metabolism
18 3 17% 3 17% 1 6%
Inositol Phosphate
Metabolism
43 4 9% 5 12% 4 9%
Amino Acid Metabolism
Ala, Asp and Glu Metabolism 43 21 49% 19 44% 18 42%
Gly, Ser and Thr Metabolism 63 11 17% 13 21% 9 14%
Cys and Met Metabolism 66 8 12% 3 5% 3 5%
Val, Leu and Ile Degradation 35 18 51% 13 37% 16 46%
Val, Leu and Ile Biosynthesis 14 10 71% 10 71% 7 50%
Lys Biosynthesis 30 13 43% 10 33% 8 27%
Lys Degradation 54 7 13% 8 15% 7 13%
Arg and Pro Metabolism 104 32 31% 26 25% 22 21%
His Metabolism 37 12 32% 13 35% 10 27%
Tyr Metabolism 66 11 17% 8 12% 9 14%
Phe Metabolism 70 11 16% 9 13% 9 13%
Trp Metabolism 69 14 20% 14 20% 9 13%
Phe, Tyr and Trp
Biosynthesis
37 26 70% 16 43% 16 43%
Each of these pathways were individually screened to make a call for active or
inactive by tracing through the List of EC numbers on the KEGG map. If majority
(almost all) of the EC number continuously connecting the pathway were present
then the pathways was marked active else inactive.
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values of >100 or < −100). (The range of flux through re-
actions was from 0 to 1000; with a threshold of 100 arbi-
trarilty selected for the purpose of analysis). Among
these 110 reactions, the majority of the reactions were
used in carbohydrate (37) and amino acid (34) metabol-
ism (i.e. 60 unique reactions after eliminating overlaps
between carbohydrates (37) and amino acid (34)).
In carbohydrate metabolism, the tricarboxylic acid
cycle (TCA cycle) was complete and active. In the
current study, we will be focusing on the seven com-
pounds of TCA cycle that play crucial roles in carbon
exchange between various pathways in the central me-
tabolism. These intermediates include: pyruvate (KEGG
compound C00022), acetoacetyl CoA (C00332), acetylyl
CoA (C00024), alpha-ketoglutarate (C00026), succinyl CoA
(C00091), fumarate (C00122) and oxaloacetate (C00036).
Studying the reaction use and fluxes involving these com-
pounds will help us understand the probable activity in
amino acid biosynthesis and degradation pathways. To
summarize these nodes in the current proteomics-based
version of our model, 60 unique reactions (associated withcarbohydrates and amino acid metabolism) were found
with some significant flux (i.e. flux was > 0.01 units).
Among these, 23 unique reactions correspond to amino
Figure 5 Major reaction distribution in the proteomics based model comprising total of 1002 reactions.
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most of the amino acid – carbohydrate connection nodes
as shown in Figure 6.
It was observed that in the carbohydrate-amino acid
network connection the majority of reactions (11 out of
23) branch in and out of alpha – ketoglutarate. The
acetyl CoA node was more centralized by connecting
the amino acids and fatty acid pathways with 8 signifi-
cantly high flux reactions. The pathway specific details
are also illustrated in the Table 2. It was observed that
when contrasted with the reactions specific to the bio-
synthesis or degradation of amino acids, the overallFigure 6 Summary of carbohydrate and amino acids connection node
pathways. Standard three-letter amino acids code is used to denote the p
highlighted as red and the branching out amino acid pathways are boxed
Acetyl Co A and Acetoacetyl Co A. The numbers of reactions for each pathanalysis suggests the presence of all but one amino acid
subsystem, cysteine and methionine metabolism.
Comparison of “model refinement with data” Vs
“reconstruction from data”
In the past, several attempts have been made to use
computational metabolic models as a scaffold for experi-
mental data integration [39-42]. Experimental data inte-
gration not only serves as a means of testing model
predictions, but can also be used to help refine the
model solution space to provide simulations that more
closely match in vivo flux states. In this study, we useds and number of active flux reaction within amino acid
athway names. The carbohydrate nodes of the central metabolism are
in blue. The purple boxes denote the fatty acids connections from
way are represented in the parenthesis.
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perimental data to understand and characterize the
metabolic network of T. fusca. For the first approach,
an MILP algorithm (analogous to Shlomi et al. [42])
was used to integrate the proteomics dataset to the
model Tfu_v2 (autobuild model). This algorithm aims
at optimizing the agreement between the experimental
data and the in silico model [42]. In this context, the
experimental information is used to assign a present
or absent call to re-channelize the flux distribution of
the network as explained by Gowen et al. [43].
Parallel to this, a second approach originating directly
from an experimental proteomic data set was used to
generate an independent model, Tfu_v3. Currently exist-
ing methods for constraint-based model reconstruction
primarily depend on the bioinformatic information such
as genomics data, biochemical data and models of re-
lated microorganisms at the initial phase of model build-
ing. The approach taken for construction of Tfu_v3
relies on the in vivo experimental evidence of the pro-
teins as the starting point of model building. While these
two methods of model construction used the same bio-
informatics and experimental data, subtle differences
in the order of process steps and algorithms, as shown
in Figure 5, used to construct the two models resulted in
vastly different functional consequences.
Besides this, another very interesting and significant
difference between Tfu_v2 and Tfu_v3 was observed in
the function of the TCA cycle. The reaction using pyru-
vate to make oxaloacetate was not found in the autobuilt
Tfu_v2 version whereas the proteomics version clearly
shows its presence (EC 6.4.1.1, Gene ID: Tfu_2557,
Tfu_1530, Tfu_0947, Tfu_1228). In addition, most of the
amino acid pathways were fully or partially incomplete
in Tfu_v2. Thus, the Tfu_v2 model had artificially high
fluxes through transport reactions to uptake external nu-
trients to satisfy simulation requirements for optimal
biomass production. The Tfu_v3 model showed most of
the pathways significantly complete except cysteine and
methionine metabolism. Besides cysteine and methio-
nine metabolism, phenylalanine metabolism was sparsely
populated, but active flux through the reaction involved
in the interconversion of phenylalanine to phenylpyru-
vate suggested making a present call for the entire phenyl-
alanine pathway. These functional differences indicate
some of the potential danger associated with over-reliance
on genome annotation (that may contain numerous errors
especially in under-characterized organisms).
Applicability of the model: biofuels and pharmaceutical
precursors
The subsystem-based analysis of central metabolism and
experimental foundation suggests the closer association
of Tfu_v3 to the in vivo biochemical system of T. fusca.While the Tfu_v3 model is the most accurate of the
three models constructed in this study, there are numer-
ous areas of metabolism that are not well-characterized.
For comparison, even the most update model of E. coli
has an account of only for 30% of the gene products in
the model [44]. Likewise, this model being the first ever
T. fusca metabolic network also opens huge scope of
pathway-focused review and improvement. Once com-
pletely functional these models provide a ground for hy-
pothesizing a target for the further study.
T. fusca is a potentially interesting organism for bio-
chemical production of sustainable fuels or industrial
chemicals. In these areas, two pathways of particular
interest are butanol and secondary metabolite biosyn-
thesis (e.g. terpenoids). The Tfu_v2 (ModelSEED auto-
built) model incorporates most of the reactions present
in the butanoate metabolism however, no active flux was
observed through most of them. Tfu_v3 based on experi-
mental dataset confirms approximately 50% of these re-
actions but also predicts no active flux through these
pathways. Thus, while production of butanol through
butanoate metabolism appears possible in terms of bio-
chemical capabilities, it remains to be explored and
demonstrated experimentally. For comparison purposes,
in 2011 a mutant strain T. fusca B6 was designed and
constructed with heterologous expression of a bifunc-
tional alcohol dehydrogenase (adhE2) for production of
1-propanol [12]. Engineered production of 1-propanol in
T. fusca provides first-step experimental evidence that
T. fusca may be usable for the production of fuels dir-
ectly from lignocellulosic raw materials.
One consideration for FBA simulations of both buta-
nol/butanoate and terpenoids is that these are secondary
pathways and utilization of these pathways are not explicitly
included in the biomass objective for growth maximization
simulations. Thus, it is not necessarily surprising that
growth simulations with no genetic designs incorporated
may not show flux through secondary pathways. However,
due to the potential for secondary metabolism in actinomy-
cetes, we considered studying the terpenoid backbone
(TBB) pathway in more detail.
With the aim of characterization, 16 reactions for the
TBB pathway were added to the model to computation-
ally test the feasibility of flux through the TBB pathway
when optimizing for the biomass production. All the re-
actions of the mevalonate pathway except R001123 had
an active flux of approximately 0.53 mmoles/gDW/h.
The reaction R01123 was responsible for isomerization re-
action between isopentenyl diphosphate (IPP or C00129)
and dimethylallyl pyrophosphate (DMAPP or C00235).
The positive flux through the reaction (R01121) lead to
the formation of IPP, as shown in Figure 7, and provided
computational support that T. fusca may possess the cap-
ability to divert the flux through the mevalonate pathway
Figure 7 TBB as from flux analysis through Mevalonate Pathway (left) and expression analysis of Non mevalonate pathway (right).
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up experiments to verify the active in vivo expression of
these pathways.
Experimental validation: expression analysis TBB pathway
genes
Different bacteria have been found to produce terpe-
noids by either the mevalonate pathway or the non-
mevalonate pathway (DXP pathway). While computa-
tional simulations demonstrated the feasibility of an ac-
tive mevalonate pathway, no clear evidence existed for
either the mevalonate or the DXP pathways. Given theFigure 8 TBB through the non-mevalonate pathway and gene annotashorter length of the DXP pathway, initial experimental
testing focused on the seven genes of the DXP pathway
(Figure 8).
Real-time PCR was used to measure mRNA transcript
levels for the genes in the DXP pathway. The details of
T. fusca genes studied and tested are listed in Table 3
along with their relative expression in Figure 9. All but one
of the required genes were found to be expressed in the
strain. The missing enzyme was 2-C-methyl-D-erythritol
4-phosphate cytidylyltransferase (EC: 2.7.7.60). This sug-
gests the presence of terpenoid backbone biosynthesis via
the DXP pathway in T. fusca.tion in T. fusca.
Table 3 T. fusca genes associated with the DXP pathway
for terpenoid biosynthesis






Tfu_1917 3580825 Complementary 2242018 2243931 1914
Tfu_0747 3578952 880259 881473 1215
Tfu_0407 3580006 458401 459324 924
Tfu_2906 3581392 Complementary 3421460 3421924 465
Tfu_0749 3578954 883104 884261 1158
Tfu_0471 3579613 532475 533476 1002
Tfu_3076 3580076 3598495 3599487 993
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Three different methodologies were applied to create
metabolic reconstructions for T. fusca . The proteomics-
based model (Tfu_v3) named iTfu296 was found to
mimic the biological growth conditions most closely. It
was observed that when cellobiose uptake rate was con-
straint as 0.25 mmoles/gDW/h gave the growth rate of
0.49 doublings/h. This was comparable to the experi-
mental growth rate of 0.43 doublings/h. This model was
built using a novel scheme for model reconstruction
based on high throughput proteomic data at the initial
model building phase.
Genomic datasets are the most standard high through-
put data currently available, but it is always a concern to
what extent the genomics information is really tran-
scribed and translated into the functional role inside the
cell. Out of 3195 genes annotated in the T. fusca genome
published in 2005, only 3117 translated into protein-
coding genes and only 1757 were associated with pre-
dicted functions [11,45]. This discrepancy between genomic
and proteomic information may be due to environmental or
evolutionary selection processes. Accurate proteomic data
provides more information about the functional activities of
the cell, as confirmed by the fact that our proteomics-basedFigure 9 Relative expression of terpenoid biosynthetic genes associa
gene with constitutive expression in T. fusca.model agreed with experimental observations better than
models built based on genomic information alone.
With the advent of standard genomics information,
genome-scale metabolic models have become a widely
used approach to gain a systems level understanding of
metabolic processes and function [31]. Every organism-
specific model that is built needs to pass through mul-
tiple levels of curation and validation based on genome
annotation, experimental evidence and (or) biochemical
literature study. Knowing that omics-data can be used to
help identify in vivo function, we applied an approach
model building based on high throughput proteomic
data. These models contain the scope of integration of
genomics, transcriptomics, proteomics, metabolomics
and phenomics data. For the current study, proteomics
data has been used to establish a significantly reliable
starting point for the metabolic model reconstruction.
This version of model Tfu_v3 is based on functional
building blocks that are more closely associated with the
phenotypic characteristics when compared to genomics
data in the hierarchy.
In a larger context, the modeling approach aims at estab-
lishing links between the molecular and cellular functions.
However, it is still hard to find complete agreement be-
tween the “biology - biochemistry” and “network models -
omics data”. It is reported that the most updated E. coli
[44] model only associates to 30% of gene products in the
model and 1/3 of the gene products are not functionally
annotated [46]. Even with this limitation, model-based sys-
tems analysis can be useful for developing hypothesis and
target for the focused study. In this case, we hypothesize
the presence of an active terpenoid backbone pathway,
which will be the focus of our follow up studies using ex-
perimental and analytical methods.
Nevertheless, this promising approach suffers with a
major limitation to date – a lack of a standardized reaction
database to build and analyze metabolic network. Due toted with the DXP pathway in T. fusca. Tfu_2950 is a housekeeping
Figure 10 Cellulose degradation reaction in presence of water: The reaction to convert cellobiose as per the experimental dataset
Tfu_0937, EC 3.2.1.21 was expressed and thus the associated reaction was added to the model.
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is almost chemically equivalent to citric acid; 2-hydroxy-
1,2,3-propanetricarboxylic acid; 2-hydroxytricarballylic acid
and have the same compound identifier on KEGG) it is dif-
ficult to assemble a non-redundant reaction database with
standard nomenclature. Current systems biology experts
are in the quest of cleaning and populating available data-
base with minimal redundancy in the hope of exhaustive
coverage of cellular biochemical reactions. Some of the ex-
amples are MetRxn and MetaCyc.
Computational analysis demonstrated the theoretical
feasibility of producing terpenoids in T. fusca, however, no
existing experimental evidence had previously supported
or demonstrated this capability. Analysis of mRNA tran-
scripts showed in vivo activity of the DXP pathway in
T. fusca providing evidence that T. fusca may be capable
of direct cellulose-to-terpenoid biosynthesis. Isoprene is
the monomeric unit for the huge family of terpenoids,Table 4 Reactions associated with Terpenoids backbone biosy











R05636 DOXP synthase (Dxs)
R05688 DOXP reductase (Dxr)
R05633 MEP synthase (IspD)
R05634 CDP-ME kinase (IspE)
R05637 CDP-MEP synthase (IspF)
R08689 HMB-PP synthase (IspG)
R05884 HMB-PP reductase (IspH)
R08209 HMB-PP reductase (IspH)
R01123 IPP delta-isomerasethus hold importance in pharmaceutical industry, per-
fumes, incense, flavoring, spices, and varnishes.
T. fusca was found to be a biofuel producing strain
after the genetic modification protocol for this strain
was established by Deng & Fong. With this systems level
characterization of secondary metabolites, it can be sug-
gested as a highly useful, robust and inexpensive strain
for industrial application. However, this opens an arena
for the scale up and optimization study to successfully
launch this strain in industrially significant microbes.
Methods
Culture conditions
Thermobifida fusca ATCC BAA-629 was grown in Hager-
dahl medium containing 1.0% cellobiose. Experiments
were conducted in Erlenmeyer flasks where 50 mL pre-
cultures of T. fusca YX were grown at 55°C and 250 rpm
for 24 hours in a 500 mL Erlenmeyer flask. Growthnthesis pathway that were added to the model Tfu_v3
hub
EC Number Equation
2.3.1.9 [c]: C00024 – > C00332
2.3.3.10 [c]: C00332 + C00024 – > C00356
1.1.1.34 [c]: C00356 – > C00418
2.7.1.36 [c]: C00418 – > C01107
2.7.4.2 [c]: C01107 – > C01143
4.1.1.33 [c]: C01143 – > C00129
5.3.3.2 [c]: C00129 – > C00235
2.2.1.7 [c]: C00118 + C00022 – > C11437
1.1.1.267 [c]: C11437 – > C11434
2.7.7.60 [c]: C11434 – > C11435
2.7.1.148 [c]: C11435 – > C11436
4.6.1.12 [c]: C11436 – > C11453
1.17.4.3 [c]: C11453 – > C11811
1.17.7.1 [c]: C11811 – > C00129
1.17.1.2 [c]: C11811 – > C00129
5.3.3.2 [c]: C00129 – > C00235
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culture and grown at 55°C and 250 rpm for 42–48 hours.Metabolic network reconstruction
Overall model construction steps illustrated in Figure 3
are as follows:
Tfu_v1: SEED. The autobuilt draft model was made in
Model SEED [36,38] and used as the draft network.
The *.xml file downloaded was converted into in-house
MetModel format to run the FBA simulations with
MetModel software.
Tfu_v2: yaml. The *.yaml autobuilt drafts were created
by our group in 2008 using the then available organism
specific annotations and reaction database from KEGG.
[27,29,43].
Tfu_v3: Proteomics. The draft model was constructed
using the output of a 2-dimensional LC-MS analysis
performed at the Manitoba Centre for Proteomics &
Systems Biology (University of Manitoba, Winnipeg,
Canada). Cellobiose grown T. fusca sample was subjected
to FASP lysis/digestion procedure (J.R. Wisnewski et al.
Nature Methods 2009. 6(5). 359–362) followed by
2D-HPLC-MS/MS acquisition using TripleTOF 5600
mass spectrometer (ABSciex, Mississauga, ON) [47].
Thirteen pairwise-concatenated fractions in the first
dimension were analyzed over a 1-hour HPLC-MS/MS
session, each. This collection yielded 276,129 MS/MS
spectra that were interrogated using an in-house
GPU-based search engine [48] and yielded identification
of 126,471 peptides (16,598 non-redundant) spanning
2101 proteins. This represents approximately 68% total
proteomic coverage. Protein identification expectation
values were computed using a Bayes’ theorem application
of its member peptide expectation values, following the
design by Beavis and Fenyo for X!tandem [49]. Over
1700 proteins have expectation values of log(e) < −10
(a one in ten-billion probability of random
miss-assignment).
Open source T. fusca (Taxon identifier: 269800) data-
base KEGG [21,22], IMG [45] and UniProt [25] was used
to map the gene identifiers to the EC numbers which
was then looked up as the search identifier in the reac-
tion database compiled in-house. Further, manual cur-
ation was done using the published biochemical literature
specifically for cellobiose utilization as explained in
Figure 10.Linear programming for flux balance analysis
In-house python scripts were used to run the FBA simula-
tions using the linear programming algorithm as shown in
the introduction.Objective function: biomass equation
This draft model aims at the growth optimization and
the best estimates used in metabolic modeling scenario
are biomass equation, which was designed by slightly
manipulating the biomass equations from closely related
species and available published information about T. fusca
growth conditions [50]. The box below shows the biomass
equation used for the simulation of all the version of the
model. The details of the compounds identifiers are listed
in the Additional file 2.
BIOMASS EQUATION
34:7964805 C00001 þ 40:1701382 C00002
þ 0:00780937 C00003 þ 0:00780937 C00006
þ 0:00780937 C00010 þ 0:00780937 C00016
þ0:00780937 C00018 þ 0:00780937 C00019
þ 0:25601316 C00025 þ 0:00780937 C00034
þ 0:59580299 C00037 þ 0:00780937 C00038
þ0:50005823 C00041 þ 0:20910125 C00044
þ 0:33354560 C00047 þ 0:23467873 C00049
þ 0:00780931 C00059 þ 0:28827498 C00062
þ0:12987656 C00063 þ 0:25601316 C00064
þ 0:20970184 C00716 þ 0:00780937 C00070
þ 0:14934101 C00073 þ 0:14026667 C00075
þ0:00780937 C00076 þ 0:05515731 C00078
þ 0:18056213 C00079 þ 0:13425080 C00082
þ 0:08898018 C00097 þ 0:00780937 C00698
þ0:43865670 C00123 þ 0:01174687 C00131
þ 0:09262265 C00135 þ 0:21542571 C00148
þ 0:23467873 C00152 þ 0:00780937 C00175
þ0:41159840 C00183 þ 0:24664683 C00188
þ 0:00780937 C00238 þ 0:00780937 C00255
þ 0:01174687 C00286 þ 0:00780937 C00305
þ0:28255111 C00407 þ 0:01174687 C00458
þ 0:01174687 C00459 þ 0:09247649 C04574
þ 0:00780937 C14818 þ 0:00780937 C14819
þ0:00780937 C00229 −− > 40:0000000 C00008
þ 39:9921906 C00009 þ 0:60239528 C00013
þ40:0000000 C00080 þ 0:00780937 C03688
Gap analysis and model comparison
The draft model consists of the list of reactions however
there are patches in the network that obstruct continu-
ous flow of flux through the pathway. These links are
filled in by using the reaction databank and suggesting
the list of reactions required to complete the network.
FBA-GAP is used to suggest the connection nodes/reac-
tions that are missing [30]. The use and application of
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et al., Gowen et al. and Vanee et al. [27,29,43]. FBA-GAP
takes a draft model and biomass reaction and uses distances
in the reaction network and mathematical optimization to
produce a list of metabolites that are necessary for biomass
production but cannot be produced or consumed by the
cell. Reactions producing and consuming this list of metabo-
lites are obtained from a reference database. These po-
tentially gap-filling reactions were manually checked
for relevant evidence such as associated proteins/en-
zymes characterized or genome annotations,. On de-
tecting the specific evidence these reaction additions
to the model wer accepted. The process is repeated
until a positive biomass flux value is obtained. In this way,
only high-confidence reactions are used to complete the
reconstruction.
Data integrations and model validation for Tfu_v2
The mixed integer linear programming algorithm (MILP)
published in 2008 by Shlomi et al. [42] was used for inte-
gration of proteomics data to the Tfu_v2 version of model.
This algorithm was re-written in python by Gowen et al.
[43] to include in our MetModel package.
Characterization of TBB pathway
Metabolic model iTfu296 or (Tfu_v3) was used to enlist
the already existing secondary metabolites production
pathway based reactions (characterized by EC numbers)
and metabolites (characterized by KEGG compound
IDs). In addition, besides studying the complete second-
ary metabolite network a focused study on terpenoids
backbone biosynthesis (TBB) pathway using mevalonate
and non-mevalonate pathway was performed using KEGG
(map00900). The reactions database of these pathways
was created using the information from KEGG as shown
in the Table 4 below.
Expression analysis of TBB pathway genes
T. fusca strain YX grown on Cellobiose media to till the
early log phase with dry cell weight of 2.005 mg/mL was
used for isolation of RNA using the Qiagen RNA Protect
and Qiagen RNAeasy kit. The total RNA was sent to
Nucleic Acid Research Facility (Virginia Commonwealth
University) for RT-PCR. Tfu_2950 was selected as
housekeeping gene to measure the relative expression
levels.Additional files
Additional file 1: Three_Versions_of_Model.xlxs. xlxs file with three
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